Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico
Open accessAbstract
BACKGROUND: As a first step in the prevention of diabetes, the International Diabetes Federation recommends identification of persons at risk using the Finnish type 2 Diabetes Risk Assessment (FINDRISC) survey. The frequency of diabetes mellitus, impaired fasting glucose, and glucose intolerance in high-risk groups identified by FINDRISC is unknown in our country. The aim of this study was to determine the frequency of diabetes mellitus, impaired fasting glucose, and glucose intolerance in higher-risk groups using a FINDRISC survey in an urban population. METHODS: We used a television program to invite interested adults to fill out a survey at a television station. An oral glucose tolerance test was performed in all persons with a FINDRISC score ≥ 15 points (high-risk and very high-risk groups). Patients were classified as normal (fasting glucose < 100 mg/dL and 2-hour glucose < 140 mg/dL), or having impaired fasting glucose (fasting glucose 100-125 mg/dL and 2-hour glucose < 140 mg/dL), glucose intolerance (fasting glucose < 126 mg/dL and 2-hour glucose 140-199 mg/dL), and diabetes mellitus (fasting glucose ≥ 126 mg/dL or 2-hour glucose ≥ 200 mg/dL). We describe the frequency of each diagnostic category in this selected population according to gender and age. RESULTS: A total of 186 patients had a score ≥ 15. The frequencies of diabetes mellitus, impaired fasting glucose, glucose intolerance, and normal glucose levels were 28.6%, 25.9%, 29.2%, and 16.2%, respectively. We found a higher frequency of diabetes mellitus and impaired fasting glucose in men than in women (33% versus 27% and 40% versus 21%, respectively) and more glucose intolerance in women than in men (34% versus 16%, P < 0.05). Patients with diabetes mellitus (52.55 ± 9.2 years) were older than those with impaired fasting glucose (46.19 ± 8.89 years), glucose intolerance (46.15 ± 10.9 years), and normal levels (41.9 ± 10.45 years, P < 0.05). We found a higher frequency of diabetes mellitus in those aged over 50 years than in younger subjects (46.15% versus 15.88%, respectively). CONCLUSION: The FINDRISC survey is a very useful tool for identifying individuals at high risk of developing diabetes and prediabetic states, especially in those older than 50 years.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
FINDRISC is the most commonly evaluated diabetes risk score worldwide and has been recommended as the best available risk assessment tool for clinical practice by a systematic review.
“Moreover, FINDRISC is the most commonly evaluated diabetes risk score worldwide [17,18,19,20,21,22,23,24,25] and has been recommended as the best available risk assessment tool for use in the clinical practice by a systematic review [11].”
From A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults (2015) · cites this paper as [25]
The Introduction says FINDRISC has been widely used and validated in different countries and epidemiologic studies, supporting its broad evaluation. It does not establish that FINDRISC is the most commonly evaluated diabetes risk score worldwide. The separate systematic-review recommendation is attributed to citation [11], not this paper. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · see citing works
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1× · see citing works
“Both are easy to implement on a large-scale in the general population, and are relatively inexpensive and available to everyone.(5,6) The International Diabetes Federation has proposed iden-”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1× · see citing works
“However, results from different long-term well designed trials have been modest in terms of prevention of microvascular and macrovascular complications.(4) Prevention and/or early diagnosis of diabetes have now emerged as more promising strategies to reduce both the prevalence of the disease and development of its com…”
BackgroundMakrilakis, K., Liatis, S., Grammatikou, S., Perrea, D., Stathi, C., Tsiligros, P., & Katsilambros, N. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.09.006 · Cited by 199 · cited 1× · see citing works
“The Finnish type 2 Diabetes Risk Assessment (FINDRISC) survey developed in 2001 has been widely used and validated in different countries and epidemiologic studies as an instrument to identify patients at risk of developing diabetes and prediabetic states.(7) The aim of this study was to evaluate the prevalence of dia…”
MethodVillalpando, S., de la Cruz, V., Rojas, R., Shamah-Levy, T., Ávila, M., Gaona, B., Rebollar, R., & Hernández, L. (2010) · Salud Pública de México · doi:10.1590/s0036-36342010000700005 · Cited by 163 · cited 5× · see citing works
“The study protocol was approved and registered with the ethics committee of the Universidad Popular Autonoma del Estado de Puebla, Mexico.”
BackgroundResultInfluentialSchwarz, P. E. H., Li, J., Reimann, M., Schutte, A. E., Bergmann, A., Hanefeld, M., Bornstein, S. R., Schulze, J., Tuomilehto, J. O., & Lindström, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2427 · Cited by 109 · cited 1× · see citing works
“We think that our cut-off (15 points) may increase the specificity of the survey, thereby decreasing the number of false-positive cases.(8,9) The population described in this study cannot be considered “normal”, in that they were selected because of their high FINDRISC score.”
BackgroundHernández-Romieu, A. C., Olaíz, A. E., Huerta-Uribe, N., & Reynoso‐Noverón, N. (2011) · Salud Pública de México · doi:10.1590/s0036-36342011000100006 · Cited by 36 · see citing works
Brodovicz, K. G., Dekker, J. M., Rijkelijkhuizen, J. M., Rhodes, T., Mari, A., Alssema, M., Nijpels, G., Williams‐Herman, D., & Girman, C. J. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03315.x · Cited by 14 · cited 1× · see citing works
“We think that our cut-off (15 points) may increase the specificity of the survey, thereby decreasing the number of false-positive cases.(8,9) The population described in this study cannot be considered “normal”, in that they were selected because of their high FINDRISC score.”
BackgroundMortalidad por diabetes mellitus: experiencia de 11 años en un hospital de segundo nivel
Gutiérrez-Vázquez, I., Burguete-Cabañas, T., Zacarías-Castillo, R., & Mata-Miranda, P. (2006) · Salud Pública de México · doi:10.1590/s0036-36342006000600001 · Cited by 5 · see citing works
Flagged first, then by citations
2 of the 11 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- [2]Burguete-Cabanas T Zacarías-Castillo R Mata-Miranda P Diabetes mellitus mortality. Eleven years experience at a second level hospital Salud Pública Mex 2006 48 445 Spanish 17326339
- [3]Hernandez-Romieu AC Elnecavé-Olaiz A Huerta-Uribe N Analysis of population survey for determining the factors associated with the control of diabetes mellitus in Mexico Salud Pública Mex 2011 53 34 39 Spanish 21340138
Cited by
Sorted by citations
Zhang, L., Zhang, Z., Zhang, Y., Hu, G., & Chen, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097865 · Cited by 130 · see citing works
Ku, G. M., & Kegels, G. (2013) · Primary care diabetes · doi:10.1016/j.pcd.2013.07.004 · Cited by 49 · see citing works
Jølle, A., Midthjell, K., Holmen, J., Carlsen, S. M., Tuomilehto, J. O., Bjørngaard, J. H., & Åsvold, B. O. (2019) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-000769 · Cited by 47 · see citing works
A Novel Testing Model for Opportunistic Screening of Pre-Diabetes and Diabetes among U.S. Adults
Zhang, Y., Hu, G., Zhang, L., Mayo, R., & Chen, L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120382 · Cited by 41 · see citing works
Impact of sex and age on the performance of FINDRISC: the HUNT Study in Norway
Jølle, A., Midthjell, K., Holmen, J., Tuomilehto, J., Carlsen, S. M., Shaw, J. E., & Åsvold, B. O. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000217 · Cited by 29 · see citing works
Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population
Wang, J., Zhang, R., Chen, R., Sun, J. M., Yang, R., Ke, X.-Y., Chen, H., & Cai, D.-H. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-633 · Cited by 34 · see citing works
“It has been used in different countries for identification of diabetic high-risk individuals [10-21].”
BackgroundAwad, A. I., & Alsaleh, F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116742 · Cited by 24 · see citing works
Milovanovic, S., Silenzi, A., Kheiraoui, F., Ventriglia, G., Boccia, S., & Poscia, A. (2018) · European Journal of Public Health · doi:10.1093/eurpub/cky009 · Cited by 18 · see citing works
Acosta-Reyes, J. L., Garrido, D. P. R., Acosta, T., Aschner, P. J., Fraga, C. A., Vázquez‐Fernández, A., Tuomilehto, J. O., & Gabriel, R. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112480 · Cited by 14 · see citing works
Diabetes Risk Scores for Hispanics Living in the United States.: A systematic review
Juarez, L., Gonzalez, J. S., Agne, A., Kulczycki, A., Pavela, G., Carson, A., Shelley, J. P., & Cherrington, A. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.05.009 · Cited by 11 · see citing works
Risco de desenvolvimento do diabetes tipo 2 em enfermeiras e sua relação com alterações metabólicas
Sánchez-Jiménez, B., Chico‐Barba, G., Rodríguez-Ventura, A. L., Sámano, R., Veruete-Bedolla, D., & Morales‐Hernández, R. M. (2019) · Revista Latino-Americana de Enfermagem · doi:10.1590/1518-8345.3002.3161 · Cited by 13 · see citing works
“Type of Patient† Serious Non-serious Outpatient and without contact with patient 8(9) 3(12) 1(3) 34(36) 6(24) 11(30) 28(30) 7(28) 6(17) 21(22) 6(24) 17(47) 3(3) 3(12) 1(3) 0.”
BackgroundRazo-Olvera, F. D. D., Reyes-Muñoz, E., Rojas-Martínez, R., Guerrero-Romero, F., Mehta, R., Dávila-Olmedo, W. E., Bello-Chavolla, O. Y., Melgarejo-Hernández, M., Durazo-Arivizu, R., & Aguilar-Salinas, C. (2020) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2020.02.006 · Cited by 2 · see citing works
“They are clearly able to distinguish cases of high and low risk but are unable to predict incidence with adequate precision.(20,21) In addition the diagnostic capacity (measured using the area under the ROC curve) of such instruments is moderate (between 0.”
Dietary gender differences in terms of the risk of atherogenesis in Poland.
Śmidowicz, A., & Reguła, J. (2015) · Acta scientiarum polonorum. Technologia alimentaria · doi:10.17306/j.afs.2015.3.37 · Cited by 2 · see citing works
Mirhadyan, L., Molaee, S., Khomami, H. M., & Leili, E. K. (2019) · Journal of Research Development in Nursing and Midwifery · doi:10.29252/jgbfnm.16.1.34 · Cited by 1 · see citing works
Prévalence de l’hyperglycémie à jeun au sein du CHU Mitsinjo Betanimena, Tuléar, Madagascar
Rakotoniaina, A., Rafaramalala, S. S., Ranaivosoa, M. K., Mampionona, A. M. R., & Rasamindrakotroka, A. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30189-5
Assessment of cardiovascular risk factors in persons with impaired glucose tolerance
Novaković, T., Mirković, Z., Milošević, N., Živković, Z., Miric, D. J., Mirković, J., Peric, V. M., & Milošević, J. (2019) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh180212048n
“32 years, which is consistent with the findings of other authors [21], while the participants in the Garcia-Alcala’s study were somewhat younger [24].”
Result
- Authors
- Garcia-Alcala, H., Soto Vega, E., Genestier Tamborero, C. N., Salinas Palma, J. L., & Hirales Tamez, O.
- Venue
- Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2012-11
- Volume
- 5
- Pages
- 403
- ISSN
- 1178-7007 (ISSN-L)
- PMC
- PMC3508657
- OpenAlex
- W2069349956
- Cited by
- 21
- References
- 11
- Citations by year
- 2025: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 3 · 2016: 1 · 2015: 3 · 2014: 2 · 2013: 2
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes Metabolic Syndrome and Obesity (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- type 2 diabetes, impaired fasting glucose, impaired glucose tolerance, FINDRISC, diabetes risk assessment, high-risk groups, prevalence, sex differences, age differences, Puebla City, urban population, oral glucose tolerance test, diabetes prevention, Puebla, Mexico, Mexico City, Latin America
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
